1. Irvine R, Johnson BL, Jr, Amstutz HC. The relationship of genitourinary tract procedures and deep sepsis after total hip replacements. Surg Gynecol Obstet. 1974;139:701–706.
2. Lowell JD, Davies JA, Bennett AH. Bladder fistula following total hip replacement using self-curing acrylic. Clin Orthop. 1975;3:131–133.
3. Pitfield J, Saxton HM. Urinary tract complications of total hip replacement. Clin Radiol. 1981;32:429–430.
4. Carter HB, Partin AW, Osterling JE, et al. The use of prostate specific antigen in the management of patients with prostate cancer: The Johns Hopkins Experience. In: Catalona WJ, Coffey DS, Karr JP, eds. Clinical aspects of prostate cancer. Assessment of new diagnostic and management procedures. New York, Elsevier, 1989;247–251.
5. Catalona WJ, Smith DS, Ratliff TL, Dopps KM, Coplen DE, Yuan JJ, et al. Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156–1161.